Nantahala Capital Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-77,337
| Closed | -$1.23M | – | 114 |
|
|
2023
Q4 | $1.23M | Sell |
77,337
-49,583
| -39% | -$787K | 0.07% | 89 |
|
|
2023
Q3 | $2.39M | Sell |
126,920
-71,175
| -36% | -$1.34M | 0.2% | 70 |
|
|
2023
Q2 | $4.48M | Sell |
198,095
-38,387
| -16% | -$868K | 0.43% | 42 |
|
|
2023
Q1 | $6.01M | Buy |
236,482
+18,109
| +8% | +$460K | 0.46% | 37 |
|
|
2022
Q4 | $3.3M | Sell |
218,373
-9,587
| -4% | -$145K | 0.21% | 54 |
|
|
2022
Q3 | $2.92M | Sell |
227,960
-12,995
| -5% | -$167K | 0.19% | 52 |
|
|
2022
Q2 | $2.36M | Sell |
240,955
-6,789
| -3% | -$66.4K | 0.12% | 64 |
|
|
2022
Q1 | $4.13M | Sell |
247,744
-15,779
| -6% | -$263K | 0.18% | 56 |
|
|
2021
Q4 | $6.69M | Buy |
+263,523
| New | +$6.69M | 0.24% | 57 |
|